Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $64.1 million.

  • Accendra Health's Depreciation & Amortization (CF) rose 403.32% to $64.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $249.8 million, marking a year-over-year decrease of 757.87%. This contributed to the annual value of $264.8 million for FY2024, which is 786.49% down from last year.
  • Per Accendra Health's latest filing, its Depreciation & Amortization (CF) stood at $64.1 million for Q3 2025, which was up 403.32% from $59.4 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Depreciation & Amortization (CF) registered a high of $74.1 million during Q1 2024, and its lowest value of $22.5 million during Q4 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $55.6 million, with a median of $63.9 million in 2024.
  • In the last 5 years, Accendra Health's Depreciation & Amortization (CF) skyrocketed by 22576.63% in 2022 and then crashed by 1746.68% in 2025.
  • Over the past 5 years, Accendra Health's Depreciation & Amortization (CF) (Quarter) stood at $22.5 million in 2021, then surged by 225.77% to $73.2 million in 2022, then dropped by 3.4% to $70.7 million in 2023, then dropped by 7.85% to $65.2 million in 2024, then dropped by 1.67% to $64.1 million in 2025.
  • Its Depreciation & Amortization (CF) was $64.1 million in Q3 2025, compared to $59.4 million in Q2 2025 and $61.2 million in Q1 2025.